Warhound raises $200M to engineer war dogs and arm them with Anduril gear

The first batch of dogs is about to be cloned and incubated and is expected to be born early next year, ideally entering service within the next two years, Lamm said. Another company owned by Colossal, Viagen, is partnering with Warhound to help clone the dogs. Lamm said Viagen’s tech has a high success rate with cloning, and Colossal currently uses it for its program to help protect endangered species. 

The startup doesn’t know yet how much it will charge for the dogs but expects to sell to parties like first responders, the Department of Defense, military service groups, and police forces. When asked about government approval, Lamm said the company has briefed many government groups about the business. 

In terms of the responsibility and safety of civilians when it comes to releasing genetically enhanced dogs, Lamm said the dog will be trained like any military working dog and will be managed by whoever buys it.

The company said it is working under the guidance of the American Humane Society to help certify Warhound’s training program for the newly created dogs that will enter service. The hope is also that when these new military dogs retire, they will enter the Society’s Military Working Dog Reunification Program, which provides a home for retired military dogs — or another program the society offers to help dogs.